Johnson & Johnson

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.

CEO

Joaquin Duato

CEOJoaquin Duato

Employees

131,900

Employees131,900

Headquarters

New Brunswick, New Jersey

HeadquartersNew Brunswick, New Jersey

Founded

1887

Founded1887

Employees

131,900

Employees131,900

JNJ Key Statistics

Market cap

347.78B

Market cap347.78B

Price-Earnings ratio

23.88

Price-Earnings ratio23.88

Dividend yield

3.40%

Dividend yield3.40%

Average volume

10.14M

Average volume10.14M

High today

$145.47

High today$145.47

Low today

$142.68

Low today$142.68

Open price

$142.75

Open price$142.75

Volume

17.68M

Volume17.68M

52 Week high

$168.85

52 Week high$168.85

52 Week low

$142.68

52 Week low$142.68

JNJ News

Benzinga 5d

FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer

On Monday, the U.S. Food and Drug Administration issued a complete response letter (CRL) to Johnson & Johnson’s JNJ Biologics License Application for a fixed co...

Seeking Alpha 5d

Johnson & Johnson says injectable Rybrevant rejected by FDA

Johnson & Johnson (NYSE:JNJ) has announced that the U.S. FDA has declined to approve an injectable version of its cancer medication Rybrevant (amivantamab-vmjw)...

TipRanks 6d

Johnson & Johnson sues Cigna’s Express Scripts, Accredo, WSJ reports

Johnson & Johnson (JNJ) sued divisions of Cigna (CI), accusing them of working with a drug-benefit middleman to drain J&J financial-assistance funds earmarked f...

Analyst ratings

54%

of 24 ratings

Buy

45.8%

Hold

54.2%

Sell